If we want continued progress against cancer, Congress must recognize that government price controls carry real human costs. Defunding innovation today means fewer cures tomorrow.
Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report.
Seven in 10 patients now live five years or more after a cancer diagnosis.
Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in the cancer death rate — the equivalent of 4.8 million fewer cancer deaths.
These astounding achievements did not happen by accident.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Cancer Breakthroughs Threatened by D.C.’s Price Controls
Sally C. Pipes
If we want continued progress against cancer, Congress must recognize that government price controls carry real human costs. Defunding innovation today means fewer cures tomorrow.
Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report.
Seven in 10 patients now live five years or more after a cancer diagnosis.
Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in the cancer death rate — the equivalent of 4.8 million fewer cancer deaths.
These astounding achievements did not happen by accident.
Read the entire op-ed in Newsmax.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.